TR201010074A1 - Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri. - Google Patents

Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri.

Info

Publication number
TR201010074A1
TR201010074A1 TR2010/10074A TR201010074A TR201010074A1 TR 201010074 A1 TR201010074 A1 TR 201010074A1 TR 2010/10074 A TR2010/10074 A TR 2010/10074A TR 201010074 A TR201010074 A TR 201010074A TR 201010074 A1 TR201010074 A1 TR 201010074A1
Authority
TR
Turkey
Prior art keywords
topical pharmaceutical
gel compositions
flurbiprofen
pharmaceutical gel
glucosamine
Prior art date
Application number
TR2010/10074A
Other languages
English (en)
Inventor
Çi̇fter Ümi̇t
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Zengi̇ner Si̇bel
Öner Levent
Original Assignee
Sanovel İlaç San.Ve Ti̇c.A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San.Ve Ti̇c.A.Ş. filed Critical Sanovel İlaç San.Ve Ti̇c.A.Ş.
Priority to TR2010/10074A priority Critical patent/TR201010074A1/tr
Priority to PL11191683T priority patent/PL2460514T3/pl
Priority to EP11191683.9A priority patent/EP2460514B1/en
Priority to SI201130083T priority patent/SI2460514T1/sl
Priority to DK11191683.9T priority patent/DK2460514T3/da
Priority to RS20130505A priority patent/RS53034B/en
Priority to PT111916839T priority patent/PT2460514E/pt
Priority to ES11191683.9T priority patent/ES2436503T3/es
Publication of TR201010074A1 publication Critical patent/TR201010074A1/tr
Priority to CY20131101063T priority patent/CY1114680T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, glukosamin ya da onun tuzları ve kondroitin sülfatla birlikte flurbiprofen ya da onun farmasötik olarak kabul edilebilir tuzlarını içeren topikal farmasötik jel bileşimleriyle ilgilidir. Daha spesifik olarak buluş, flurbiprofen ya da onun farmasötik olarak kabul edilebilir tuzları, glukosamin ya da onun tuzları, kondroitin sülfat ve dimetil sülfoksit içeren topikal farmasötik jel bileşimleriyle ilgilidir. Buluş ayrıca sözü edilen topikal farmasötik jel bileşimlerini hazırlamak için bir proses ve bu bileşimlerin eklem ve kıkırdak bozukluklarıyla ilişkili osteoartrit, ağrı ve iltihap semptomlarının tedavisinde kullanımıyla ilgilidir.
TR2010/10074A 2010-12-03 2010-12-03 Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri. TR201010074A1 (tr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
TR2010/10074A TR201010074A1 (tr) 2010-12-03 2010-12-03 Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri.
PL11191683T PL2460514T3 (pl) 2010-12-03 2011-12-02 Żelowe kompozycje farmaceutyczne flurbiprofenu, glukozaminy i chondroityny do podawania miejscowego
EP11191683.9A EP2460514B1 (en) 2010-12-03 2011-12-02 Topical pharmaceutical gel compositions of flurbiprofen, glucosamine and chondroitin
SI201130083T SI2460514T1 (sl) 2010-12-03 2011-12-02 Topični farmacevtski gelski sestavki flurbiprofena, glukozamina in hondroitina
DK11191683.9T DK2460514T3 (da) 2010-12-03 2011-12-02 Topiske farmaceutiske gelsammensætninger af fluriprofen, glucosamin og chondroitin
RS20130505A RS53034B (en) 2010-12-03 2011-12-02 TOPICAL PHARMACEUTICAL GEL COMPOSITIONS OF FLURBIPROPHENE, GLUCOSAMINE AND CHONDROITINE
PT111916839T PT2460514E (pt) 2010-12-03 2011-12-02 Composições farmacêuticas tópicas em gel de flurbiprofeno, glucosamina e condroitina
ES11191683.9T ES2436503T3 (es) 2010-12-03 2011-12-02 Composiciones farmacéuticas tópicas de gel de flurbiprofeno, glucosamina y condroitina
CY20131101063T CY1114680T1 (el) 2010-12-03 2013-11-27 Φαρμακευτικες συνθεσεις γελης φλουρμπιπροφαινης, γλυκοζαμινης και χονδροïτινης για τοπικη χρηση

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/10074A TR201010074A1 (tr) 2010-12-03 2010-12-03 Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri.

Publications (1)

Publication Number Publication Date
TR201010074A1 true TR201010074A1 (tr) 2012-06-21

Family

ID=44041604

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/10074A TR201010074A1 (tr) 2010-12-03 2010-12-03 Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri.

Country Status (9)

Country Link
EP (1) EP2460514B1 (tr)
CY (1) CY1114680T1 (tr)
DK (1) DK2460514T3 (tr)
ES (1) ES2436503T3 (tr)
PL (1) PL2460514T3 (tr)
PT (1) PT2460514E (tr)
RS (1) RS53034B (tr)
SI (1) SI2460514T1 (tr)
TR (1) TR201010074A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2809306A2 (en) * 2012-01-31 2014-12-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi New pharmaceutical compositions of flurbiprofen and glucosamin
CN115300634A (zh) * 2022-09-05 2022-11-08 淄博佐佑健身器材有限公司 一种含有氨糖软骨素的液态硅胶及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099013A1 (en) * 2000-01-24 2003-12-04 Omni Nutraceuticals, Inc. Acetaminophen/non-steroidal anti-inflamatory drug-glucosamine composition
US20080227747A1 (en) * 2007-03-15 2008-09-18 Tabbiner Philip Composition and methods for treating or preventing degenerative joint and cardiovascular conditions
WO2010013279A2 (en) * 2008-07-29 2010-02-04 Stewart Italia Srl Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099013A1 (en) * 2000-01-24 2003-12-04 Omni Nutraceuticals, Inc. Acetaminophen/non-steroidal anti-inflamatory drug-glucosamine composition
US20080227747A1 (en) * 2007-03-15 2008-09-18 Tabbiner Philip Composition and methods for treating or preventing degenerative joint and cardiovascular conditions
WO2010013279A2 (en) * 2008-07-29 2010-02-04 Stewart Italia Srl Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug

Also Published As

Publication number Publication date
RS53034B (en) 2014-04-30
CY1114680T1 (el) 2016-10-05
EP2460514B1 (en) 2013-08-28
PT2460514E (pt) 2013-11-06
SI2460514T1 (sl) 2013-12-31
EP2460514A1 (en) 2012-06-06
ES2436503T3 (es) 2014-01-02
DK2460514T3 (da) 2013-11-04
PL2460514T3 (pl) 2014-01-31

Similar Documents

Publication Publication Date Title
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
UA110310C2 (uk) Сполуки n-арилтриазолу як антагоністи рецепторів лізофосфатидної кислоти (lpar)
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
IN2014DN09434A (tr)
MX348823B (es) Formulaciones estables de linaclotida.
MX2011013032A (es) Inhibidores de fosfatidilinositol 3-cinasa.
IN2014DN09347A (tr)
ZA201200016B (en) Topical micro-emulsion for the treatment of rheumatic disorders
TN2014000046A1 (en) Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
UA112420C2 (uk) Інгібітори апоптозу та їх застосування
IN2015DN02894A (tr)
MX2013002118A (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
HK1197235A1 (zh) 二氫吡唑、其藥物組合物及其治療生育障礙的用途
MX2011008645A (es) Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa.
MX2012006265A (es) Formulaciones disacaridas hipersulfatadas.
MX2015001657A (es) Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar).
TR201010074A1 (tr) Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri.
WO2013115737A3 (en) New pharmaceutical compositions of flurbiprofen and glucosamin
WO2011160821A3 (en) Organic salts and co-crystals of phenylbutyric acid
MX2013002295A (es) 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
PT2505195E (pt) Composições farmacêuticas tópicas de cetoprofeno e metilsulfonilmetano
WO2012020021A9 (en) Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
TR201009220A1 (tr) Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri.